|
|
|
|
| LEADER |
00000cam a22000002 4500 |
| 001 |
1089818734 |
| 003 |
DE-627 |
| 005 |
20230509090810.0 |
| 007 |
tu |
| 008 |
900228s1981 xx ||||| 00| ||eng c |
| 035 |
|
|
|a (DE-627)1089818734
|
| 035 |
|
|
|a (DE-576)019818734
|
| 035 |
|
|
|a (DE-599)BSZ019818734
|
| 035 |
|
|
|a (OCoLC)07688598
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 082 |
0 |
|
|a 615/.7822
|
| 245 |
1 |
0 |
|a Narcotic antagonists
|b naltrexone pharmacochemistry and sustained-release preparations
|c eds.: Robert E. Willette; Gene Barnett
|
| 264 |
|
1 |
|a Rockville, Md
|b National Inst. on Drug Abuse
|c 1981
|
| 300 |
|
|
|a VIII, 276 S.
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 490 |
1 |
|
|a DHHS publication
|a ADM
|v 81-102.
|
| 490 |
1 |
|
|a NIDA research monograph series
|v 28
|
| 583 |
1 |
|
|a Archivierung prüfen
|c 20200919
|f DE-640
|z 1
|2 pdager
|
| 810 |
2 |
|
|a USA
|b Department of Health and Human Services
|t DHHS publication
|v 81-102.
|9 1981,102.
|w (DE-627)130337803
|w (DE-576)9130337801
|w (DE-600)592531-9
|x 0737-6863
|7 ns
|
| 810 |
2 |
|
|a National Institute on Drug Abuse
|t NIDA research monograph
|v 28
|9 28
|w (DE-627)129444421
|w (DE-576)516303244
|w (DE-600)195692-9
|x 0361-8595
|7 ns
|
| 951 |
|
|
|a BO
|
| ELC |
|
|
|b 1
|
| LOK |
|
|
|0 000 xxxxxcx a22 zn 4500
|
| LOK |
|
|
|0 001 214143727X
|
| LOK |
|
|
|0 003 DE-627
|
| LOK |
|
|
|0 004 1089818734
|
| LOK |
|
|
|0 005 20020606000000
|
| LOK |
|
|
|0 008 900228||||||||||||||||ger|||||||
|
| LOK |
|
|
|0 040
|a DE-21
|c DE-627
|d DE-21
|
| LOK |
|
|
|0 852
|a DE-21
|
| LOK |
|
|
|0 852 1
|c KB 13 A 865
|9 00
|
| LOK |
|
|
|0 935
|a krim
|
| LOK |
|
|
|0 936ln
|a k9.7.4
|
| ORI |
|
|
|a SA-MARC-krimdoka001.raw
|
| SIG |
|
|
|a UB: KB 13 A 865
|
